In the past few years, TOX [thymocyte selection-associated high-mobility group (HMG) box] has been described as a potential new diagnostic marker for cutaneous T-cell lymphoma (CTCL) [16]. The gene discussed is TOX; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.